Continuous Glucose Monitoring Market Trends and Overview

The Continuous Glucose Monitoring Market was valued at USD 7.6 billion in 2022 and is projected to reach USD 10.56 billion by 2030, with a compound annual growth rate (CAGR) of 4.2% during the forecast period from 2023 to 2030.

Continuous Glucose Monitoring (CGM) is a rapidly expanding market that offers significant growth opportunities. CGM devices provide real-time glucose monitoring for individuals with diabetes, enabling them to manage their condition more effectively. The increasing prevalence of diabetes worldwide, coupled with the growing demand for advanced diabetes management solutions, is driving the market's growth.

The market's growth is also fueled by technological advancements in CGM devices, such as improved accuracy, smaller form factors, and enhanced connectivity features. These innovations have made CGM devices more user-friendly and convenient, leading to increased adoption among patients.

Furthermore, the rising awareness about the benefits of continuous glucose monitoring among healthcare professionals and patients is contributing to market growth. CGM devices offer several advantages over traditional glucose monitoring methods, including the ability to detect glucose fluctuations in real-time, provide trend data, and alert users to potential hypoglycemic or hyperglycemic events.

Geographically, North America dominates the CGM market due to the high prevalence of diabetes and the presence of key market players in the region. However, the Asia Pacific region is expected to witness significant growth during the forecast period, driven by the increasing diabetic population and improving healthcare infrastructure.

In conclusion, the Continuous Glucose Monitoring Market is poised for substantial growth in the coming years. Factors such as the rising prevalence of diabetes, technological advancements, and increasing awareness about the benefits of CGM devices are driving market expansion. With a projected CAGR of 4.2% over the forecast period, the market is expected to reach USD 10.56 billion by 2030.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3055

KEY MARKET SEGMENTATION:

By Component

• Sensors
• Transmitters
• Receivers

By End-Use Outlook

• Hospitals
• Home Care
• Others

By Connectivity Outlook

• Bluetooth
• 4G

Some of the major key players are as follows:

Dexcom Inc, Medtronic Inc, Abbott Laboratories, Ypsomed AG, GlySens Incorporated, Ascensia Diabetes Care, F. Hoffmann-La Roche Ltd., and other players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com